| Accession Number: | 0001209191-23-054333 |
| Date: | 2023-11-01 |
| Issuer: | EAGLE PHARMACEUTICALS, INC. (EGRX) |
| Original Submission Date: |
TARRIFF SCOTT
C/O EAGLE PHARMACEUTICALS, INC.
50 TICE BLVD., SUITE 315
WOODCLIFF LAKE, NJ 07677
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2023-11-01 | S | 10,925 | d | $13.82 | 556,141 | direct | ||
| COMMON STOCK | 2023-11-02 | S | 10,694 | d | $13.87 | 545,447 | direct | ||
| COMMON STOCK | 2023-11-01 | 0 | $0.00 | 992,623 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | these transactions were made pursuant to a rule 10b5-1 trading plan adopted by the reporting person on june 15, 2023. |
| f2 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $13.64 to $14.10 inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). |
| f3 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $13.50 to $14.20 inclusive. |
| f4 | the shares are held by the tarriff 2016 generation skipping exempt family trust dtd 12/28/2016 (the "trust") for the benefit of the reporting person's spouse and children. the reporting person does not have investment control over the shares held by the trust and disclaims beneficial ownership of the shares, except to any pecuniary interest therein, if any. |
